Skip to search formSkip to main contentSkip to account menu

Complement Factor B

Known as: C3PA, Complement Protein Factor B, Complement Protein B 
A glycine-rich, heat-labile serum glycoprotein that contains a component of the C3 CONVERTASE ALTERNATE PATHWAY (C3bBb). Bb, a serine protease, is… 
National Institutes of Health

Related topics

Related topics

15 relations
CFB geneComplement 3Complement C3 ConvertasesComplement C3b

Narrower (2)

Complement Factor BaProperdin Factor Bf

Broader (1)

Immunologic Factors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Production and functional activity of a recombinant von Willebrand factor-A domain from human complement factor B.
Factor B is a five-domain 90 kDa serine protease proenzyme which is part of the human serum complement system. It binds to other… 
1993
1993
Successive activation of the platelet-derived growth factor beta receptor and platelet-derived growth factor B genes correlates with the genesis of human choriocarcinoma.
The hydatidiform mole is a benign disease of the placenta characterized by the absence of the maternal genome. Approximately 3… 
Highly Cited
1986
Highly Cited
1986
Nucleotide sequence of the cDNA coding for human complement C1r.
C1r is a zymogen of a serine protease that is involved in the activation of the first component of the classical pathway of the… 
1986
1986
Complement abnormalities during an epidemic of group B meningococcal infection in children.
During an epidemic of group B meningococcal infection mean values obtained in 96 consecutively affected children showed a… 
1981
1981
Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.
Activated Factor B (Bb), the central serine esterase of the alternative pathway of complement activation, exhibits restricted… 
1980
1980
Partial sequence of human complement component factor B: novel type of serine protease.
Factor B (a component of the alternative pathway of complement) is believed to contain the proteolytic site of the complex… 
1978
1978
Complement activity in middle ear effusions.
Evidence for complement utilization in middle ear fluids (MEF) from patients with otitis media with effusion was sought. It was… 
1978
1978
Complement-mediated phagocytosis of Pseudomonas aeruginosa.
The nature of the opsonic factors in nonimmune human serum for six blood culture isolates of Pseudomonas aeruginosa was… 
1977
1977
Chronic serous otitis media: an immune complex disease.
In characterizing the immunochemical and biochemical nature of middle ear effusions (MEE) of chronic serous otitis media (SOM… 
1975
1975
Complement activation in seropositive and seronegative rheumatoid arthritis. 125I-C1q binding capacity and complement breakdown products in serum and synovial fluid.
1. The detection and quantitation of immune complex-like material in synovial fluid and in serum from patients with joint…